entertainment -WSS

entertainment

author：leisure time 2025-10-01 12:11:17 - browse：55441

FDA's Peter Marks talks with STAT's Adam Feuerstein — Peter Marks, the FDA's top regulator of gene therapies (right), speaks with STAT's Adam Feuerstein in San Francisco. Sarah Gonzalez/Peopletography for STAT

SAN FRANCISCO — Peter Marks, the Food and Drug Administration’s top regulator of gene therapies, seems very comfortable with granting some form of full approval to Elevidys, the Sarepta Therapeutics gene therapy for Duchenne muscular dystrophy, based on his comments to me on Monday night during our “fireside chat” at a STAT event.

To be clear, Marks declined to comment specifically about the ongoing FDA review of Elevidys. I tried. However, Marks described a “hypothetical case” in the context of my Sarepta questions that clearly suggested the failure of an Elevidys confirmatory study in October didn’t bother him all that much.

“Hypothetically, if you had a product that used an aggregate scale and all of the components of that aggregate scale looked pretty good, or nearly all of them look pretty good, but the aggregate, for various reasons, didn’t come out perfectly. We approved products based on that,” Marks told me.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Making AI in medicine accessible to smaller, and rural hospitals

WSS

Can CDC director Mandy Cohen drive consensus in Washington?

Federal judge rules Oregon’s tough new gun law is constitutional

H5N1 communication has been strictly for the birds

Use wet bulb globe temperature, not heat index, to protect workers

Readout LOUD podcast: What to know about H5N1 bird flu

Telehealth startups turn to complex chronic diseases

entertainment

entertainment

focus

Dobbs anniversary: the lost opportunity of abortion as health care

H5N1 bird flu: what we're starting to learn about infection in cows

Jerome Adams on the need for new antivirals for Covid

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

BioMarin wins approval for gene therapy to treat hemophilia A

Researchers on aging grapple with how to calculate biological age

The high cost of giving birth even with insurance

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

Tori Bowie and the unacceptable rates of Black maternal death

Readout LOUD podcast: What to know about H5N1 bird flu

Wikipedia

Care demand spikes challenge UnitedHealth’s provider arm

Steward Health Care files for bankruptcy

Europe sees delivery challenges ahead on Alzheimer's therapies

What nurses really want: sufficient staffing for patient care

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Sanofi strikes deal with Novavax, boosting the vaccine maker

explore

hotspot

hotspot

hotspot